Foot Locker Stock a...
Health Care: Drugs
GlaxoSmithKline PLC (GSK: NYSE)
$52.35 -0.12 | -0.23%
06/19/13 - 09:30 AM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 52.47 |
| 52 Week High | 54.00 |
| 52 Week Low | 41.68 |
| Avg. Daily Vol. (Mil) | 2.92 |
| Beta (3 year) | 0.47 |
| Share Related Items | |
| Mkt Cap (Mil) | 129,061.93 |
| Shares Out (Mil) | 2,459.73 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 4.20 |
| Annual Dividend | 2.20 |
| Payout Ratio | 88.00 |
| Financial Strength | |
| Quick Ratio | 0.80 |
| Current Ratio | 1.20 |
| LT Debt/ Equity | 2.58 |
| Total Debt / Equity | 2.89 |
| Valuation Ratios | |
| Price Earnings | 19.60 |
| Price/Sales | 3.11 |
| Price/Book | 12.69 |
| Price/Cash Flow | 13.30 |
| Per Share Data | |
| Earnings | 2.68 |
| Sales | 16.84 |
| Book Value | 4.14 |
| Cash Flow | 3.95 |
| Business Summary | |
|---|---|
| GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products. | |
| General Information | |
| 980 Great West Road
Brentford Middlesex, TW8 9GS |
|
| www.gsk.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 98681 | |
| CEO: Sir Andrew Witty | |
| Short Interest | |
| Current Month (Mil) | 2.93 |
| Previous Month (Mil) | 2.39 |
| Short Interest Ratio (Days) | 1.30 |
| Management Effectiveness | |
| Return on Equity | 67.90 |
| Return on Assets | 10.60 |
| Return on Investments | 18.90 |
| Profitability | |
| Gross Margin | 76.10 |
| EBIT Margin | 26.70 |
| Profit Margin | 16.70 |
Portfolios with GSK
- Portfolio NameUser Type
- Usersamuel sandler kosher sausage
- ContributorStocks Rising On Unusual Vo...
- ProBill Miller - Legg Mason Ca...
- ProKen Fisher - Fisher Investm...
- Usercurrent holdings
- Contributor7 Big-Pharma Stocks With Un...
- Contributor10 Dividend Stocks Held by ...
- UserKAREL VON ZOETE
- UserMARIA DEL HUERTO
- ContributorHighest-Yielding Drug Stocks
Latest GSK Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 06.17.13 | 01:06 pm
- Amicus Delays U.S. Approval Filing for Fabry Disease Drug 06.17.13 | 08:06 am
- 5 Buy-Rated Dividend Stocks: MO, PVR, GSK, EEP, EC 06.13.13 | 11:06 am
- GlaxoSmithKline PLC (GSK): Today's Featured Drugs Winner 06.12.13 | 05:06 pm
- GlaxoSmithKline PLC Stock Buy Recommendation Reiterated (GSK) 06.12.13 | 10:06 am
- Playing Big Pharma's Strong Dividend Yields 06.11.13 | 01:06 pm
- FDA's Flawed Call On Aveo's Tivozanib 06.07.13 | 05:06 pm
- As If Amarin Needs Another Worry, Here Comes A Vascepa FDA Panel 06.06.13 | 11:06 am
- 'Mad Money' Lightning Round: I'm Buying Under Armour 06.04.13 | 06:06 am
- Cramer's 'Mad Money' Recap: Out With the New 06.03.13 | 08:06 pm
Press Releases for GSK
- BREOâ¿¢ ELLIPTAâ¿¢ Gains US Approval For The Treatment Of COPD - PR Newswire 05.10.13 | 04:05 pm
- GlaxoSmithKline CFO Interviewed On Q1 2013 Financial Results - PR Newswire 04.24.13 | 07:04 am
- FDA Advisory Committee Recommends Approval Of BREOâ¿¢ ELLIPTAâ¿¢ For The Treatment Of COPD - PR Newswire 04.17.13 | 05:04 pm
- GlaxoSmithKline, Triangle Community Foundation Issue Call For Applications Totaling $400,000 In GSK IMPACT Awards - PR Newswire 04.17.13 | 11:04 am
- GlaxoSmithKline Issues Call For Applications Totaling $400,000 In GSK IMPACT Awards - PR Newswire 04.17.13 | 11:04 am
- GlaxoSmithKline And Liberty Property Trust/Synterra Partners Transform The Work Environment With The Opening Of Five Crescent Drive Today - PR Newswire 04.06.13 | 06:04 pm
- GlaxoSmithKline And Liberty Property Trust/Synterra Partners Transform The Work Environment With The Opening Of Five Crescent Drive - PR Newswire 04.05.13 | 10:04 am
- Texas A&M System And GlaxoSmithKline Receive U.S. Government Approval To Establish Influenza Vaccine Facility In Texas - PR Newswire 03.26.13 | 11:03 am
- Americans Rate Themselves And Their Communities As Healthy, Despite Research Showing The Opposite - PR Newswire 03.06.13 | 09:03 am
- GlaxoSmithKline Progresses Multi-city Discussion Focused On Improving The Health Of US Communities - PR Newswire 02.06.13 | 09:02 am
Partner Headlines for GSK
- Dynavax Down on Heplisav Delay - Analyst Blog - Zacks 06.12.13 | 12:06 am
- Parexel Trying To Clear Three-Weeks-Tight Buy Point - Investor's Business Daily 06.11.13 | 06:06 pm
- FDA Panel Positive on GSK's Avandia - Analyst Blog - Zacks 06.07.13 | 10:06 pm
- Impax Reduces Workforce - Analyst Blog - Zacks 06.07.13 | 01:06 am
- What Must Be In The Ideal Biopharmaceutical Portfolio? - Seeking Alpha 06.05.13 | 09:06 am
- GSK/Genmab Report Positive Arzerra Data - Analyst Blog - Zacks 05.31.13 | 11:05 pm
- Stocks Market News for May 30, 2013 - Market News - Zacks 05.30.13 | 03:05 pm
- After Hours Most Active for May 29, 2013 : SIRI, GE, SPF, CSCO, SYMC, VOD, NLY, NRF, BAC, GSK, MSFT, STEI - NASDAQ 05.29.13 | 08:05 pm
- UPDATE: Deutsche Bank Upgrades GlaxoSmithKline to a Buy on Risk/Reward Move to Positive - Benzinga 05.28.13 | 09:05 am
- Elan Rejects Royalty Offer Again - Analyst Blog - Zacks 05.24.13 | 10:05 pm
